Specific aspects of high blood pressure in the elderly

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 3, Issue SUPPL. 1, 2002, Pages

  Blacher, Jacques ^a   Safar, Michel ^a  

^a HÔPITAL BROUSSAIS   (France)

Author keywords

Arterial stiffness; Cardiovascular risk; Elderly; Epidemiology; Haemodynamic; Hypertension; Pulse pressure; Wave reflections

Indexed keywords

AMINOGUANIDINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTROGEN; INTEGRIN; NITRATE; SPIRONOLACTONE;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DRUG MECHANISM; HEART HEMODYNAMICS; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; INDIVIDUALIZATION; KIDNEY FAILURE; MORBIDITY; MORTALITY; NONHUMAN; PREDICTION; PREVALENCE; PULSE PRESSURE; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; VASCULAR FRAGILITY;

EID: 0036757739     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.3317/jraas.2002.025     Document Type: Article

References (53)

1. Glynn RJ, Field TS, Rosner B et al. Evidence for a positive relation between blood pressure and mortality in elderly people. Lancet 1995;345:825-9.
2. Reynolds E, Baron RB. Hypertension in women and the elderly. Some puzzling and some expected findings of treatment studies. Postgrad Med 1996;100:58-70.
3. Burt VL, Whelton P, Roccella EJ et al. Prevalence of hypertension in the US adult population: results from the third National Health and Nutrition Survey, 1988-1991. Hypertension 1995;25:305-13.
4. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 2001;345:479-86.
5. National High Blood Pressure Education Program Working Group. National High Blood Pressure Education Program Working Group Report on Hypertension in the Elderly. Hypertension 1994;23:275-85.
6. Insua JT, Sacks HS, Lau TS et al. Drug treatment of hypertension in the elderly: a meta-analysis. Ann Intern Med 1994;121:355-62.
7. European Working Party on High Blood Pressure in the Elderly Group. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial. Lancet 1985;1:1349-54.
8. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991;265:3255-64.
9. Dahlof B, Lindholm LH, Hansson L et al. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension. Lancet 1991;338:1281-5.
10. MRC Working Party Medical Research Council of treatment of hypertension in older adults : principal results. BMJ 1992;304:405-12.
11. Staessen JA, Fagard R, Thijs L et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997;350: 757-64.
12. Gueyffier F, Bulpitt C, Boissel JP et al. Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group. Lancet 1999;353:793-6.
13. Collins R, Peto, R, Mac Mahon S et al. Blood pressure, stroke and coronary heart disease. Part 2, short term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827-38.
14. Safar ME. Therapeutic trials and large arteries in hypertension. Am Heart J 1988;115:702-10.
15. Society of actuaries. Build and blood pressure study. 1959. Chicago, III: Society of Actuaries; 1959.
16. Stamler J, Neaton JD, Wentworth DN. Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease. Hypertension 1989;13:2-12.
17. Black HR. The paradigm has shifted to systolic blood pressure. Hypertension 1999;34:386-7.
18. Darné B, Girerd X, Satar M, Cambien F, Guize L. Pulsatile versus steady component of blood pressure. A cross-sectional and prospective analysis on cardiovascular mortality. Hypertension 1989;13:392-400.
19. Madhavan S, Ooi WL, Cohen H, Alderman MH. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension 1994;23:395-401.
20. Scuteri A, Cacciafesta M, Di Bernardo MG et al. Pulsatile versus steady-state component of blood pressure in elderly females: an independent risk factor for cardiovascular disease? J Hypertens 1995;13:185-91.
21. Witteman JC, Grobbee DE, Valkenburg HA et al. J-shaped relation between change in diastolic pressure and progression of aortic atherosclerosis. Lancet 1994;343:504-7.
22. Benetos A, Safar M, Rudnichi A et al. Pulse pressure. A predictor of long-term cardiovascular mortality in a french male population. Hypertension 1997;30:1410-5.
23. Blacher J, Staessen JA, Girerd X et al. Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch Intern Med 2000;160:1085-9.
24. Benetos A, Zureik M, Morcet J et al. A decrease in diastolic blood pressure combined with an increase in systolic blood pressure is associated with high cardiovascular mortality. J Am Coll Cardiol 2000;35:673-80.
25. Franklin SS, Larson MG, Khan SA et al, Does the relation of blood pressure to coronary heart disease risk change with ageing? The Framingham Heart Study. Circulation 2001;103:1245-9.
26. Alderman MH, Cohen H, Madhavan S. Distribution and determinants of cardiovascular events during 20 years of successful antihypertensive treatment. J Hypertens 1998;16:761-9.
27. Nichols WW, O'Rourke MF. Vascular impedance. McDonald's blood flow in arteries: theoretical, experimental and clinical principles. 4th edn, London, Arnold, 1998.
28. Milnor WR, Hemodynamics, 2nd edn, ed. W. Wilkins. 1989, Baltimore. 211-41.
29. Franklin SS, Gustin W 4th, Wong ND, Larson MG, Weber MA, Kannel WB, Levy D. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997;96:308-15.
30. Franklin SS, Jacobs MJ, Wong ND, L'Italien GJ, Lapuerta P. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension 2001;37:869-74.
31. Safar ME, London GM. The arterial system in human hypertension, In: Swales JD (Ed). Textbook of hypertension, Blackwell Scientific, London, 1994;85-102.
32. Safar ME, Blacher J, Mourad JJ, London GM. Stiffness of carotid artery wall material and blood pressure in humans. Stroke 2000;31:782-90.
33. Küng CF, Lüscher TF. Different mechanisms of endothelial dysfunction with aging and hypertension in rat aorta. Hypertension 1995;25:194-200.
34. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109-42.
35. Blacher J, Pannier B, Guerin A, Marchais S, Safar M, London G. Impact of carotid stiffness on cardiovascular and all-cause mortality in end-stage renal failure. Hypertension 1998;32:570-4.
36. Blacher J, Asmar R, Djane S, London G, Safar M. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999;33:1111-17.
37. Meaume S, Rudnichi A, Lynch A, Bussy C, Sebban C, Benetos A, Safar ME. Aortic pulse wave velocity as a marker of cardiovascular disease in subjects over 70 years old. J Hypertens 2001;19:871-7.
38. Meaume S, Benetos A, Henry OF, Rudnichi A, Safar ME. Aortic pulse wave velocity predicts cardiovascular mortality in subjects >70 years of age. Arterioscler Thromb Vasc Biol 2001;21:2046-50.
39. Blacher J, Guerin A, Pannier B, Marchais S, Safar M, London G. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999;99:2434-9.
40. Laurent S, Boutouyrie P, Asmar R et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001;37:1236-41.
41. Boutouyrie P, Tropeano AI, Asmar R et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 2002;39: 10-15.
42. London G, Blacher J, Pannier B, Guerin A, Marchais S, Safar ME. Arterial wave reflections and survival in end-stage renal failure. Hypertension 2001;38:434-8.
43. Guerin A, Blacher J, Pannier B, Marchais S, Safar M, London G. Impact of aortic stiffness attenuation on survival of patients in end-stage renal disease. Circulation 2001;103:987-92.
44. Safar ME, London GM, for the Clinical Committee of Arterial Structure and Function. Therapeutic studies and arterial stiffness in hypertension: recommendations of the European Society of Hypertension. J Hypertens 2000;18:1527-35.
45. Safar ME. Antihypertensive effects of nitrates in chronic human hypertension. J Appl Cardiol 1990;5:69-81.
46. Taylor MG. Wave travel in arteries and the design of the cardiovascular system. In: Pulsatile Blood Flow, Attinger EO (Ed). 1964, McGraw Hill: New York. p. 343-7.
47. Kato H, Suzuki H, Tajima S, Ogata Y, Tominaga T, Sato A, Saruta T. Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells. J Hypertension 1991;9:17-22.
48. Albaladejo P, Bouaziz H, Duriez M, Gohlke P, Levy B, Safar M, Benetos A. Angiotensin converting enzyme inhibition prevents the increase in aortic collagen in rats. Hypertension 1994;23:74-82.
49. Benetos A, Levy BI, Lacolley P, Taillard F, Duriez M, Safar ME. Role of angiotensin II and bradykinin on aortic collagen following converting-enzyme inhibition in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 1997;17-3196-201.
50. Lacolley P, Safar ME, Lucet B, Ledudal K, Labat C, Benetos A. Prevention of aortic and cardiac fibrosis by spironolactone in old normotensive rats. J Am Coll Cardiol 2001;37:662-7.
51. Blacher J, Amah G, Girerd X et al. Association between plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension. Am J Hypertens 1997;10:1326-34.
52. Davies PE. Flow-mediated endothelial mechanotransduction. Physiol Rev 1995;75:519-60.
53. Kass DA, Shapiro EP, Kawaguchi M et al. Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation 2001;104:1464-70.